Vaxcyte (5VA) Ratios
Vaxcyte Ratios
DE:5VA's free cash flow for Q2 2026 was $-532.46M. For the 2026 fiscal year, DE:5VA's free cash flow was decreased by $-19.37M and operating cash flow was $-513.10M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.91 | 12.75 | 7.54 | 23.26 | 8.93 |
| Quick Ratio | 7.91 | 12.75 | 7.54 | 23.26 | 8.93 |
| Cash Ratio | 0.85 | 2.77 | 2.73 | 20.60 | 2.40 |
| Solvency Ratio | -2.06 | -2.18 | -2.34 | -4.07 | -2.40 |
| Operating Cash Flow Ratio | -3.19 | -3.23 | -2.04 | -4.21 | -4.23 |
| Short-Term Operating Cash Flow Coverage | -107.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 1.27B | $ 1.58B | $ 928.50M | $ 889.99M | $ 216.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.02 | 0.02 | 0.02 | 0.05 |
| Debt-to-Equity Ratio | 0.09 | 0.02 | 0.02 | 0.02 | 0.06 |
| Debt-to-Capital Ratio | 0.08 | 0.02 | 0.02 | 0.02 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.13 | 1.06 | 1.13 | 1.06 | 1.14 |
| Debt Service Coverage Ratio | -121.12 | 0.00 | 0.00 | -107015.00 | -13801.86 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -116128.00 | -14810.00 |
| Debt to Market Cap | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.68 | 0.58 | 0.30 | 0.28 | 0.32 |
| Net Debt to EBITDA | -0.07 | 0.71 | 0.94 | 3.82 | 0.54 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 83.00% | 81.46% | 85.95% | 96.22% | 96.53% |
| Return on Assets (ROA) | -25.17% | -13.21% | -28.57% | -22.21% | -30.86% |
| Return on Equity (ROE) | -28.55% | -14.03% | -32.43% | -23.44% | -35.24% |
| Return on Capital Employed (ROCE) | -32.52% | -16.89% | -37.07% | -24.05% | -35.07% |
| Return on Invested Capital (ROIC) | -32.45% | -16.87% | -36.86% | -23.91% | -34.45% |
| Return on Tangible Assets | -25.17% | -13.21% | -28.57% | -22.21% | -30.86% |
| Earnings Yield | -12.21% | -4.65% | -6.59% | -7.18% | -8.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -4.82 | -3.71 | -3.05 | -2.63 | -2.34 |
| Free Cash Flow Per Share | -4.92 | -3.89 | -3.75 | -2.72 | -2.46 |
| Dividend Paid and CapEx Coverage Ratio | -47.81 | -20.18 | -4.37 | -29.21 | -18.52 |
| Capital Expenditure Coverage Ratio | -47.81 | -20.18 | -4.37 | -29.21 | -18.52 |
| Operating Cash Flow Coverage Ratio | -2.86 | -6.37 | -10.16 | -9.51 | -7.23 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -10.66% | -4.76% | -5.98% | -5.67% | -10.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.20 | -21.54 | -15.17 | -13.92 | -12.34 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.34 | 3.02 | 4.92 | 3.26 | 4.35 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.38 | -21.02 | -16.73 | -17.63 | -9.65 |
| Price-to-Operating Cash Flow Ratio | -9.58 | -22.06 | -20.56 | -18.24 | -10.18 |
| Price-to-Earnings Growth (PEG) Ratio | -0.17 | 2.62 | -0.75 | -0.18 | 0.35 |
| Enterprise Value Multiple | -8.54 | -21.58 | -14.62 | -10.72 | -12.24 |
| Enterprise Value | 6.33B | 9.67B | 5.73B | 2.29B | 1.18B |
| EV to EBITDA | -8.54 | -21.58 | -14.62 | -10.72 | -12.24 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -9.46 | -20.36 | -15.72 | -13.00 | -9.25 |
| EV to Operating Cash Flow | -9.66 | -21.36 | -19.32 | -13.45 | -9.75 |
| Tangible Book Value Per Share | 19.73 | 27.10 | 12.77 | 14.70 | 5.47 |
| Shareholders’ Equity Per Share | 19.73 | 27.10 | 12.77 | 14.70 | 5.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.86 | 0.98 | 0.74 | 0.76 | 1.21 |
Currency in USD